abstract |
The present invention concerns an in vitro method for the determination of the plasma inhibitor to activated Factor X (XaI), which is an alpha-2-globulin of molecular weight 58,000-65,000, and which has been termed variously as antithrombin III, heparin cofactor and alpha-2-antitrypsin. |